Surgery Partners

Surgery Partners EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Surgery Partners (SGRY) as of Oct 10, 2026 is 389.50 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 501.40 M USD — a change of -22.32% (lower).

EBITDA

389.50 MUSD

YoY

-22.32%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Surgery Partners is 2025 389.50 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Surgery Partners was 2024 501.40 M USD. It decreases by -22.32% lower compared to the previous year.

The Surgery Partners EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
145.24 M USD
Jan 1, 2019
310.00 M USD
Jan 1, 2020
277.80 M USD
Jan 1, 2021
401.00 M USD
Jan 1, 2022
460.00 M USD
Jan 1, 2023
446.10 M USD
Jan 1, 2024
501.40 M USD
Jan 1, 2025
389.50 M USD
The Surgery Partners EBITDA history
YEAREBITDAYoY
389.50 MUSD-22.32%
501.40 MUSD+12.40%
446.10 MUSD-3.02%
460.00 MUSD+14.71%
401.00 MUSD+44.35%
277.80 MUSD-10.39%
310.00 MUSD+113.44%
145.24 MUSD-42.33%
251.86 MUSD+2.68%
245.28 MUSD+36.83%
179.25 MUSD+171.98%
65.91 MUSD—
Access this data via the Eulerpool API
Get Free API Key

Surgery Partners Stock analysis

What does Surgery Partners do? Surgery Partners Inc is an American company specializing in specialized surgical services in the United States. It was founded in 1997 and is headquartered in Nashville, Tennessee. The company focuses on outpatient surgical procedures, providing a variety of medical services including eye surgery, endoscopy, ENT surgery, gynecology, orthopedic surgery, plastic surgery, and urology. Surgery Partners has over 180 surgical centers and practices in 32 states. It expanded its services through the acquisition of Symbion Healthcare in 2017, offering anesthesia services, pain management, diagnostics, and laboratory services. The company also emphasizes excellent service and has partnerships with hospitals to expand its surgical services. Surgery Partners is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Surgery Partners stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Surgery Partners is 389.50 M USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Surgery Partners changed from 501.40 M USD to 389.50 M USD, representing a -22.32% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Surgery Partners since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Surgery Partners historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Surgery Partners

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Surgery Partners